Literature DB >> 21279941

Incidence of intraventricular hemorrhage and post hemorrhagic hydrocephalus in preterm infants.

Negar Sajjadian1, Hossein Fakhrai, Ramin Jahadi.   

Abstract

Germinal matrix-intraventricular hemorrhage (IVH) is the most common variety of neonatal intracranial hemorrhage and is characteristics of the premature infant. The importance of the lesion relates not only to its high incidence but to their attendant complications (IC: hydrocephalus). Brain sonography is the procedure of choice in diagnosis of germinal matrix- intraventricular hemorrhage and hydrocephalus. In this study we have used brain sonography for detection of intraventricular hemorrhage and post hemorrhagic hydrocephalus and their incidences. The studied population was consisted of premature neonate (birth weight equal or less than 1500 g and gestational age equal or less than 37 weeks) who admitted in Mofid Hospital NICU (Tehran, Iran) during a one year period. For all neonate (including criteria) brain sonography in first week of life was done and in presence of IVH, serial Brain sonography was done weekly for detection of hydrocephalus. A total of 57 neonate entered the study. Intraventricular-germinal matrix hemorrhage was seen in 64.4% (35 patients). Forty percent of patients with intraventricular-germinal matrix hemorrhage had grade I, 11% grade II, 25.7% grade III, 2.8% grade VI. Hydrocephalus was detected in 20 percent of patients who had intraventricular-germinal matrix hemorrhage. That incidence of IVH in our study in comparison with other area and situation is higher. Hydrocephaly had direct relation with severity of IVH. This shows that with control of risk factor of IVH, we can control Post hemorrhagic hydrocephalus.

Entities:  

Mesh:

Year:  2010        PMID: 21279941

Source DB:  PubMed          Journal:  Acta Med Iran        ISSN: 0044-6025


  8 in total

Review 1.  Neonatal posthemorrhagic hydrocephalus from prematurity: pathophysiology and current treatment concepts.

Authors:  Shenandoah Robinson
Journal:  J Neurosurg Pediatr       Date:  2012-03       Impact factor: 2.375

Review 2.  Infantile posthemorrhagic hydrocephalus.

Authors:  Vasilios Tsitouras; Spyros Sgouros
Journal:  Childs Nerv Syst       Date:  2011-09-17       Impact factor: 1.475

3.  Lack of relationship between cord blood erythropoietin and intraventricular hemorrhage in premature neonates: a controversial result.

Authors:  Khadijehsadat Najib; Zahra Hashemi; Mozhgan Moghtaderi; Parisa Pishdad; Narjes Pishva; Fatemehsadat Najib
Journal:  Childs Nerv Syst       Date:  2018-07-05       Impact factor: 1.475

4.  Long-term Outcomes and Risk Factors Related to Hydrocephalus After Intracerebral Hemorrhage.

Authors:  Rong Hu; Chao Zhang; Jiesheng Xia; Hongfei Ge; Jun Zhong; Xuanyu Fang; Yongjie Zou; Chuan Lan; Lan Li; Hua Feng
Journal:  Transl Stroke Res       Date:  2020-06-08       Impact factor: 6.829

Review 5.  Long-term neurodevelopmental outcomes after preterm birth.

Authors:  Farin Soleimani; Farzaneh Zaheri; Fatemeh Abdi
Journal:  Iran Red Crescent Med J       Date:  2014-06-05       Impact factor: 0.611

6.  Risk factors and short-term complications of high-grade intraventricular hemorrhages in preterm neonates in training hospitals of Alborz.

Authors:  Alireza Jashni Motlagh; Azamolmolouk Elsagh; Elham Sedighipoor; Mostafa Qorbani
Journal:  Iran J Child Neurol       Date:  2021

7.  Assessing haemorrhage-critical values of cerebral blood flow by modelling biomechanical stresses on capillaries in the immature brain.

Authors:  Irina Sidorenko; Varvara Turova; Nikolai Botkin; Andrey Kovtanyuk; Laura Eckardt; Ana Alves-Pinto; Ursula Felderhoff-Müser; Esther Rieger-Fackeldey; Renée Lampe
Journal:  Sci Rep       Date:  2020-08-26       Impact factor: 4.379

8.  The Frequency of Intraventricular Hemorrhage and its Risk Factors in Premature Neonates in a Hospital's NICU.

Authors:  Behnaz Basiri; Mohammad Kazem Sabzehei; Maryam Shokouhi Solgi; Elham Khanlarzadeh; Mojdeh Mosheiri
Journal:  Iran J Child Neurol       Date:  2021
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.